These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2115037)

  • 1. Response of chemostat cultures of Pseudomonas aeruginosa to carbapenems and other beta-lactams.
    Wu PJ; Livermore DM
    J Antimicrob Chemother; 1990 Jun; 25(6):891-902. PubMed ID: 2115037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of beta-lactams against Pseudomonas aeruginosa strains by Ro 48-1256, a bridged monobactam inhibitor of AmpC beta-lactamases.
    Livermore DM; Chen HY
    J Antimicrob Chemother; 1997 Sep; 40(3):335-43. PubMed ID: 9338484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of OmpD2 and chromosomal beta-lactamase in carbapenem resistance in clinical isolates of Pseudomonas aeruginosa.
    Satake S; Yoneyama H; Nakae T
    J Antimicrob Chemother; 1991 Aug; 28(2):199-207. PubMed ID: 1778851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative activity of meropenem against Pseudomonas aeruginosa strains with well-characterized resistance mechanisms.
    Livermore DM; Yang YJ
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():149-59. PubMed ID: 2553657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro activity of biapenem, compared with imipenem and meropenem, against Pseudomonas aeruginosa strains and mutants with known resistance mechanisms.
    Chen HY; Livermore DM
    J Antimicrob Chemother; 1994 May; 33(5):949-58. PubMed ID: 8089068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imipenem and meropenem induced resistance to beta-lactam antibiotics in Pseudomonas aeruginosa.
    Giacometti A; Siquini FM; Cirioni O; Petroni S; Scalise G
    Eur J Clin Microbiol Infect Dis; 1994 Apr; 13(4):315-8. PubMed ID: 8070438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance of Pseudomonas aeruginosa mutants with altered control of chromosomal beta-lactamase to piperacillin, ceftazidime, and cefsulodin.
    Bryan LE; Kwan S; Godfrey AJ
    Antimicrob Agents Chemother; 1984 Mar; 25(3):382-4. PubMed ID: 6426382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of meropenem with class I chromosomal beta-lactamases.
    Yang YJ; Livermore DM
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():207-17. PubMed ID: 2808208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of Pseudomonas-Derived Cephalosporinase and Metallo-β-Lactamases in Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Korea.
    Cho HH; Kwon GC; Kim S; Koo SH
    J Microbiol Biotechnol; 2015 Jul; 25(7):1154-62. PubMed ID: 25907063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial Effects of β-Lactams on Imipenem-Resistant Ceftazidime-Susceptible Pseudomonas aeruginosa.
    Wi YM; Choi JY; Lee JY; Kang CI; Chung DR; Peck KR; Song JH; Ko KS
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of cephalosporinase in carbapenem resistance of clinical isolates of Pseudomonas aeruginosa.
    Zhou XY; Kitzis MD; Gutmann L
    Antimicrob Agents Chemother; 1993 Jun; 37(6):1387-9. PubMed ID: 8328794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors that influence the evolution of beta-lactam resistance in beta-lactamase-inducible strains of Enterobacter cloacae and Pseudomonas aeruginosa.
    Aronoff SC; Shlaes DM
    J Infect Dis; 1987 May; 155(5):936-41. PubMed ID: 3104483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [in vitro activity of carbapenems against Enterobacteriaceae and Pseudomonas aeruginosa hyperproducers of group 1 chromosomal beta-lactamases].
    Martínez-Beltrán J; Calderón C; Sierra MP; Alvarez M; Cantón R
    Enferm Infecc Microbiol Clin; 1997 Sep; 15 Suppl 1():20-6. PubMed ID: 9410065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection and properties of Pseudomonas aeruginosa variants resistant to beta-lactam antibiotics.
    Cullman W; Büscher KH; Dick W
    Eur J Clin Microbiol; 1987 Aug; 6(4):467-73. PubMed ID: 3117536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects on beta-lactam susceptibility of phenotypic induction and genotypic derepression of beta-lactamase synthesis.
    Shannon K; Phillips I
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():15-22. PubMed ID: 3102451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationships of carbapenems to the antagonism of the antipseudomonal activity of other beta-lactam agents and to the beta-lactamase inducibility in Pseudomonas aeruginosa: effects of 1beta-methyl group and C-2 side chain.
    Kanazawa K; Nouda H; Sumita Y; Sunagawa M
    J Antibiot (Tokyo); 1999 Feb; 52(2):142-9. PubMed ID: 10344568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudomonas aeruginosa beta-lactamase as a defence against azlocillin, mezlocillin and piperacillin.
    Jacobs JY; Livermore DM; Davy KW
    J Antimicrob Chemother; 1984 Sep; 14(3):221-9. PubMed ID: 6436226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance patterns of Pseudomonas aeruginosa to carbapenems and piperacillin/tazobactam.
    Mokaddas EM; Sanyal SC
    J Chemother; 1999 Apr; 11(2):93-6. PubMed ID: 10326738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between the usage of carbapenem antibiotics and the incidence of imipenem-resistant Pseudomonas aeruginosa.
    Fujimura S; Nakano Y; Sato T; Shirahata K; Watanabe A
    J Infect Chemother; 2007 Jun; 13(3):147-50. PubMed ID: 17593500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interplay of impermeability and chromosomal beta-lactamase activity in imipenem-resistant Pseudomonas aeruginosa.
    Livermore DM
    Antimicrob Agents Chemother; 1992 Sep; 36(9):2046-8. PubMed ID: 1329641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.